324 related articles for article (PubMed ID: 30565244)
1. RAG gene defects at the verge of immunodeficiency and immune dysregulation.
Villa A; Notarangelo LD
Immunol Rev; 2019 Jan; 287(1):73-90. PubMed ID: 30565244
[TBL] [Abstract][Full Text] [Related]
2. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
3. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
Niehues T; Perez-Becker R; Schuetz C
Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
[TBL] [Abstract][Full Text] [Related]
4. HyperIgE in hypomorphic recombination-activating gene defects.
Castiello MC; Brandas C; Capo V; Villa A
Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
[TBL] [Abstract][Full Text] [Related]
6. RAG Deficiency: Two Genes, Many Diseases.
Delmonte OM; Schuetz C; Notarangelo LD
J Clin Immunol; 2018 Aug; 38(6):646-655. PubMed ID: 30046960
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
[TBL] [Abstract][Full Text] [Related]
8. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
9. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
10. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
[TBL] [Abstract][Full Text] [Related]
11. The Clinical and Genetic Spectrum of 82 Patients With
Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
Front Immunol; 2020; 11():900. PubMed ID: 32655540
[No Abstract] [Full Text] [Related]
12. Omenn syndrome does not live by V(D)J recombination alone.
Marrella V; Maina V; Villa A
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
[TBL] [Abstract][Full Text] [Related]
13. Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.
John T; Walter JE; Schuetz C; Chen K; Abraham RS; Bonfim C; Boyce TG; Joshi AY; Kang E; Carvalho BT; Mahajerin A; Nugent D; Puthenveetil G; Soni A; Su H; Cowan MJ; Notarangelo L; Buchbinder D
J Clin Immunol; 2016 Oct; 36(7):725-32. PubMed ID: 27539235
[TBL] [Abstract][Full Text] [Related]
14. RAG-dependent primary immunodeficiencies.
Sobacchi C; Marrella V; Rucci F; Vezzoni P; Villa A
Hum Mutat; 2006 Dec; 27(12):1174-84. PubMed ID: 16960852
[TBL] [Abstract][Full Text] [Related]
15. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
Ital J Pediatr; 2012 Mar; 38():8. PubMed ID: 22424479
[TBL] [Abstract][Full Text] [Related]
16. Transplantation after CD45-ADC corrects Rag1 immunodeficiency in congenic and haploidentical settings.
Pala F; Corsino C; Calzoni E; Villa A; Pittaluga S; Palchaudhuri R; Bosticardo M; Notarangelo LD
J Allergy Clin Immunol; 2024 Jan; 153(1):341-348.e3. PubMed ID: 37567393
[TBL] [Abstract][Full Text] [Related]
17. Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies.
Villa A; Sobacchi C; Vezzoni P
Isr Med Assoc J; 2002 Mar; 4(3):218-21. PubMed ID: 11908269
[TBL] [Abstract][Full Text] [Related]
18. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
Pasic S; Djuricic S; Ristic G; Slavkovic B
Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
[TBL] [Abstract][Full Text] [Related]
19. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
Bosticardo M; Pala F; Notarangelo LD
Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.
Farmer JR; Foldvari Z; Ujhazi B; De Ravin SS; Chen K; Bleesing JJH; Schuetz C; Al-Herz W; Abraham RS; Joshi AY; Costa-Carvalho BT; Buchbinder D; Booth C; Reiff A; Ferguson PJ; Aghamohammadi A; Abolhassani H; Puck JM; Adeli M; Cancrini C; Palma P; Bertaina A; Locatelli F; Di Matteo G; Geha RS; Kanariou MG; Lycopoulou L; Tzanoudaki M; Sleasman JW; Parikh S; Pinero G; Fischer BM; Dbaibo G; Unal E; Patiroglu T; Karakukcu M; Al-Saad KK; Dilley MA; Pai SY; Dutmer CM; Gelfand EW; Geier CB; Eibl MM; Wolf HM; Henderson LA; Hazen MM; Bonfim C; Wolska-Kuśnierz B; Butte MJ; Hernandez JD; Nicholas SK; Stepensky P; Chandrakasan S; Miano M; Westermann-Clark E; Goda V; Kriván G; Holland SM; Fadugba O; Henrickson SE; Ozen A; Karakoc-Aydiner E; Baris S; Kiykim A; Bredius R; Hoeger B; Boztug K; Pashchenko O; Neven B; Moshous D; Villartay JP; Bousfiha AA; Hill HR; Notarangelo LD; Walter JE
J Allergy Clin Immunol Pract; 2019; 7(6):1970-1985.e4. PubMed ID: 30877075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
